ULBP1 and Huntington disease: To evaluate the potential of different myeloid cell subsets from pSS patients to activate NK cells, we investigated expression of ligands for activating NK receptor NKG2D such as MICa/b and ULBP1 or for inhibitory receptors such as PCNA on cDC2, cDC1, and in Mo from these individuals and in HD (Fig 2C and Appendix Fig S4A–C).